| Modulation of vascular endothelial function by low-density lipoprotein cholesterol with aging: influence of habitual exercise. | |
| | |
MedLine Citation:
|
PMID: 19114985 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Aging is associated with reduced endothelium-dependent dilation (EDD) and increased risk for cardiovascular disease (CVD), but the mechanisms are incompletely understood. Clinically elevated plasma low-density lipoprotein cholesterol (LDL-C) is associated with impaired EDD. The purpose of this study was to determine whether circulating LDL-C within the "normal" range modulates EDD in healthy older adults and whether young age or habitual aerobic exercise protects against this adverse effect. METHODS: In 83 healthy men with optimal/near optimal LDL-C (<130 mg/dl) or borderline high LDL-C (130-159 mg/dl), EDD (brachial artery flow-mediated dilation, FMD), and endothelium-independent dilation (sublingual glyceryl trinitrate, GTN) were assessed. RESULTS: FMD was 35% lower in older nonexercising men with borderline high LDL-C vs. optimal/near optimal LDL-C (3.1 +/- 0.5 vs. 4.8 +/- 0.4%Delta, P < 0.05), whereas the GTN response did not differ (P = 0.86). In contrast, FMD was similar between groups of young nonexercising men and between groups of older exercising men differing in LDL-C (P = 0.89-0.95). FMD was inversely related to LDL-C among the older nonexercising men (r = -0.43, P < 0.001), whereas there was no relation in the other groups (P > 0.05). CONCLUSIONS: Borderline high plasma LDL-C is associated with impaired EDD in older sedentary men, but not in young sedentary or older exercising men. Thus, modest elevations in plasma LDL-C within the normal range may contribute to the increased risk of CVD in sedentary older men by exacerbating vascular endothelial dysfunction, whereas resistance to this adverse influence may help explain the enhanced endothelial function and reduced CVD risk associated with young age and regular aerobic exercise. |
| | |
Authors:
|
Ashley E Walker; Iratxe Eskurza; Gary L Pierce; Phillip E Gates; Douglas R Seals |
Related Documents
:
|
3945185 - Delayed effects of prolonged exercise on serum lipoproteins. 9042095 - Haemostatic markers, inflammatory parameters and lipids in male and female patients in ... 12853535 - Cardiopulmonary effects of lipid emulsions in patients with ards. 7827295 - Geographic variations in structure and composition of gallstones and their correlation ... 23365505 - Effects of a herbal drink on cycling endurance performance. 23595205 - Additive effects of beta-alanine and sodium bicarbonate on upper-body intermittent perf... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2008-12-25 |
Journal Detail:
|
Title: American journal of hypertension Volume: 22 ISSN: 1941-7225 ISO Abbreviation: Am. J. Hypertens. Publication Date: 2009 Mar |
Date Detail:
|
Created Date: 2009-02-20 Completed Date: 2009-04-10 Revised Date: 2011-06-30 |
Medline Journal Info:
|
Nlm Unique ID: 8803676 Medline TA: Am J Hypertens Country: United States |
Other Details:
|
Languages: eng Pagination: 250-6 Citation Subset: IM |
Affiliation:
|
Department of Integrative Physiology, University of Colorado, Boulder, Colorado, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Age Factors Aged Aging / physiology* Anthropometry Body Mass Index Cardiovascular Diseases / blood, epidemiology Cholesterol, LDL / blood* Exercise / physiology* Habits* Humans Male Middle Aged Physical Fitness / physiology* Risk Factors Vascular Endothelial Growth Factor A / blood* Young Adult |
| Grant Support | |
ID/Acronym/Agency:
|
AG000279/AG/NIA NIH HHS; AG006537/AG/NIA NIH HHS; AG013038/AG/NIA NIH HHS; AG022241/AG/NIA NIH HHS; AG031617/AG/NIA NIH HHS; F31 AG031617-01/AG/NIA NIH HHS; M01 RR000051-441342/RR/NCRR NIH HHS; R01 AG006537-20/AG/NIA NIH HHS; R01 AG022241-02/AG/NIA NIH HHS; R37 AG013038-09/AG/NIA NIH HHS; RR 00051/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, LDL; 0/Vascular Endothelial Growth Factor A |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF s...
Next Document: Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?